|
Match
|
Document |
Document Title |
|
|
US20130230604 |
ORAL IRON DEFICIENCY THERAPY
Methods of normalizing iron levels, treating iron deficiency and disorders related thereto, such as anemia, as described. Pharmaceutical compositions effective for such treatments are also described. |
|
|
US20110002881 |
TREATMENT AND PROPHYLAXIS
This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present... |
|
|
US20110020270 |
TREATMENT AND PROPHYLAXIS
This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing... |
|
|
US20110183009 |
Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered... |
|
|
US20130259954 |
Liquid for Treatment of Citrus Greening Disease and Treatment Method Using Same
Provided are: a liquid for treatment of Citrus greening disease, which is capable of curing citrus trees with Citrus greening disease; and a treatment method using the liquid. The liquid for... |
|
|
US20150202224 |
METHOD OF TREATING IRON DEFICIENCY ANEMIA
Methods for predicting responsiveness of a subject to iron therapy and treatment methods related thereto. Such methods can be useful with respect to conditions, disorders, or diseases associated... |
|
|
US20110244057 |
COMBINATION THERAPIES WITH TOPIRAMATE FOR SEIZURES, RESTLESS LEGS SYNDROME, AND OTHER NEUROLOGICAL CONDITIONS
The invention provides compositions and methods of treating various conditions, including neurological conditions, with pharmaceutical compositions including a sulfamate (e.g., topiramate) and... |
|
|
US20120093910 |
NON-HORMONAL VAGINAL CONTRACEPTIVE
The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present... |
|
|
US20090297628 |
Use of iron in the form of a stone extract as stimulus of the synthesis of collagen by skin fibroblasts
Use of a stone extract as stimulant of the synthesis of collagen by skin fibroblasts. |
|
|
US20140343480 |
SYSTEMS, METHODS, AND COMPOSITIONS FOR CROSS-LINKING
Various agents and additives for cross-linking treatments are identified in disclosed studies. The characteristics of the various agents and additives may be advantageously employed in... |
|
|
US20110305774 |
TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS
Activation of HIV-1 replication causes oxidative stress, which in turn potentiates HIV-1 replication. The common basis for the compounds of the present invention is: A) the capacity of... |
|
|
US20130011495 |
ANTIFUNGAL COMPOUNDS AND USE THEREOF
The present invention relates to an antifungal composition including at least two compounds selected from among the group consisting of cysteine, salicylic acid, iron(II) sulfate and... |
|
|
US20110052722 |
Toleration Iron Supplement Compositions
The invention relates to compositions and methods for the treatment or prophylaxis of iron deficiency, and in particular of iron deficiency anemia, by administering a composition containing an... |
|
|
US20100317519 |
Mixtures and methods for the induction of resistance in plants
Mixtures are described comprising two or more compounds selected from at least two of the following groups: i) salicylic acid and/or its functional analogous products (ESA), ii) promoting... |
|
|
US20100266647 |
Optical Blurring Pigment Composition Suitable for Use in Cosmetics
Compositions comprising a gel system made from a combination of a fractal network of nanoparticles and translucent macroscopic particles, titanium dioxide and other color pigments is disclosed.... |
|
|
US20120100119 |
HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE SURFACTANTS
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide... |
|
|
US20120064052 |
Hydrolysis Resistant Organomodified Trisiloxane Surfactants
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide... |
|
|
US20110251067 |
Hydrolysis Resistant Organomodified Trisiloxane Surfactants
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide... |
|
|
US20130309380 |
METHODS FOR PRESERVING FRESH PRODUCE
Methods of preserving fresh produce with a produce preservative which extends the shelf life of fresh produce, particularly cut fresh produce, and preserves the texture, flavor, appearance,... |
|
|
US20130129810 |
IRON OXIDE NANOPARTICLES FOR USE IN TREATING NON-INFECTIOUS INFLAMMATORY DISORDERS
In accordance with the present disclosure there are provided iron oxide nanoparticles for use in the treatment of non-infectious inflammatory disorders. Also provided by the present disclosure is... |
|
|
US20130295197 |
Formed lyocell articles for selective binding of monovalent heavy metal ions, especially thallium and cesium ions and radioactive isotopes thereof
Shaped lyocell cellulose articles are provided for binding heavy metal ions and radioactive isotopes thereof. The shaped articles include one or more hexacyanoferrates that are incorporated in a... |
|
|
US20130243720 |
Iron(II)-Containing A Treatments for Hyperphosphatemia
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable... |
|
|
US20140234437 |
IRON SUPPLEMENT COMPOSITION
In one of its aspects, the present invention provides a composition comprising: (i) a non-encapsulated iron salt, and (ii) a carrier comprising digestible edible oil that is a liquid at 20° C.... |
|
|
US20130209577 |
Buffered Upper GI Absorption Promoter
The present invention relates to compositions of an active pharmaceutical compound or nutritional ingredient with one or more buffering agents between a pH of 1.0 and 6.0, preferably 2.0 and 4.0.... |
|
|
US20130323325 |
COMPOSITION COMPRISING MIXED METAL COMPOUNDS AND XANTHAN GUM
The present invention provides a composition comprising (i) a mixed metal compound containing at least one trivalent metal selected from iron (lll) and aluminium and at least one divalent metal... |
|
|
US20110195108 |
ANTIVIRAL AGENT
An antiviral agent is provided which can inactivate a wide range of viruses. Products that include such an antiviral agent are also provided. The present invention provides an antiviral agent that... |
|
|
US20090136594 |
Functionalization of Micro-And Nano Particles for Selective Attachment to Calcium Biomineral Surfaces
The present invention includes compositions, methods, devices and kits for magnetizing a biological particle by contacting a biological particle with a ferrous or magnetic particle that is able to... |
|
|
US20110166077 |
COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPY
The present invention provides the use of acryloyl distamycin derivatives, in particular α-bromo- or α-chloro-acryloyl distamycin derivatives, in combination with radiotherapy, for the treatment... |
|
|
US20140186467 |
COMPOSITION AND USE FOR ERADICATION OF HIV, TREATMENT OF AIDS AND OTHER DISEASES INCLUDING TUBERCULOSIS IN A HUMAN
A composition comprising at least one penicillin, at least one iron source, and at least one oil, method of making, and method of use thereof are described. Although suitable for many forms and... |
|
|
US20090317488 |
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically... |
|
|
US20120195974 |
CONTROLLING MEALYBUGS
The invention disclosed in this document concerns controlling mealybugs. |
|
|
US20090117168 |
Device and method for attaracting diseased cells and foreign substances
An implantable device for attracting diseased cells or foreign substances circulating within bodily fluid channels is disclosed. The device comprises a frame, an attachment means for maintaining... |
|
|
US20080213345 |
Delivering Iron to an Animal
The invention provides a method for delivery iron to an animal. This invention further provides a method for treating iron deficiency in an animal. |
|
|
US20070292463 |
COMPOSITIONS AND METHODS COMPRISING ENERGIZABLE PARTICLES FOR HEALTH USE
The present invention provides a composition comprising a topical composition base and a plurality of particles selected from the group consisting of magnetic particles, particles comprising... |
|
|
US20100150898 |
COMPOUNDS AND METHODS FOR THE TREATMENT OF AIRWAY DISEASES AND FOR THE DELIVERY OF AIRWAY DRUGS
Chronic obstructive airway diseases are treated by administering an osmotically active compound such as a salt, sugar, sugar alcohol, or organic osmolyte to the afflicted airway surface. The... |
|
|
US20150050261 |
DIETARY AND NUTRITIONAL SUPPLEMENTS CONTAINING AN OMEGA-3 FATTY ACID OF PLANT-BASED ORIGIN AND A FOLATE DERIVATIVE
The present invention relates to dietary and nutritional supplements comprising various vitamins, minerals and nutrients, including an omega-3 fatty acid of plant-based origin and a folate derivative. |
|
|
US20150150800 |
MINERAL SUPPLEMENTATION OF BEVERAGES
The present invention is directed to metal supplementation of beverages. More particularly, it is directed to a metal containing complex coacervate core micelle comprising a negatively charged... |
|
|
US20090035385 |
COMPOSITIONS INCLUDING IRON
Compositions and methods for prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal. In a first embodiment, the composition includes about 10 mg to... |
|
|
US20100330199 |
ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability... |
|
|
US20090041858 |
Haemostatic Compositions Thickened by Polymers Containing Nitrogen Moieties
The present invention is the development of haemostatic compositions that use nitrogen containing organic polymers in combination with haemostatic agents to create a gel form. Compositions... |
|
|
US20110294665 |
BIOACTIVE AGENT, PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, FRESHNESS KEEPING AGENT, AND PLANT AND ANIMAL GROWTH PROMOTING AGENT
The subject of the present invention is to provide a bioactivator which is useful as a medicine, growth promoting agent for plants and animals, and the like, wherein the bioactive effectiveness of... |
|
|
US20100135950 |
Iron(II)-Containing Treatments for Hyperphosphatemia
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable... |
|
|
US20100303928 |
ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase... |
|
|
US20150209336 |
ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability... |
|
|
US20100233245 |
NANOPARTICLE COMPOSITION AND PROCESS THEREOF
The present invention relates to nanoparticle composition comprising cellulose nanofibers embedded with nanosized material. More particularly the present invention relates to cellulose nanofibers... |
|
|
US20090304816 |
METHOD AND COMPOSITION FOR TREATING AND DIAGNOSING RESTLESS LEGS SYNDROME
A method of treating Restless Legs Syndrome (RLS) comprises the joint administration of an agent selected from dopamine turnover increasing agent and dopaminergic receptor exciting agent, in... |
|
|
US20100172916 |
SUBSTITUTED HYDROXYPHENYLAMINE COMPOUNDS
The present invention relates to new substituted hydroxyphenylamine based modulators of hormone and/or pigment levels, pharmaceutical compositions thereof, and methods of use thereof. |
|
|
US20130243852 |
ADJUVANT COMPOSITIONS AND METHODS OF POTENTIATING HDAC INHIBITORS USED TO TREAT VARIOUS DISEASES
A composition and method for potentiating, sensitizing, and/or amplifying at least one HDAC inhibitor targeting at least one disease in a patient is provided. In one embodiment, the composition is... |
|
|
US20130108710 |
Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient
Provided is an antimalarial drug which is useful for prevention and treatment of infectious diseases caused by malaria parasites. A preventive and/or therapeutic agent for malaria, which contains,... |
|
|
US20090280191 |
PREVENTIVE REMEDIAL THERAPEUTIC AGENT FOR PHOSPHORUS IMPAIRMENT, ORAL AGENT FOR ADSORBING PHOSPHATE ION CONTAINED IN FOOD, BEVERAGE AND CHEMICAL, AND PROCESS FOR PRODUCING THEM
The present invention provides agents for preventing, improving or treating phosphorus-related disorders and oral preparations; agents high in biosafety and phosphorus adsorptive power, which... |